Videos by Topic


Addiction | Alcohol | Drugs

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Adolescents

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Athletics | Exercise

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Pregnancy

The process by which a female produces an offspring in their womb once the male and female zygotes have combined into a single embryo until birth.

Embryo

The offspring in the womb, from the moment 2 zygotes co-exist up until the 11th week of pregnancy, is medically referred to as "Embryo"

Fetus

The offspring in the womb, beginning on the 11th week of pregnancy, has graduated from "Embryo" to "Fetus"

Newborn

The offspring, now emerged from the womb and ending the female's pregnancy.

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Cancer

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Children

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









COVID-19

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Disease

An abnormality caused due to pathophysiological response to external or internal factors.

Disorder

A disruption in normal functioning of mind or body due to a disease, genetic factor or trauma.

Syndrome

A set or collection of various identifying signs and symptoms that characterizes a certain disease or disorder.

Condition

An abnormal state of physical or mental health that interferes with usual activities or the feeling of well-being.

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Food | Obesity

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Girls ♀ Women

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Infections | Immune System

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Injury | Pain | Violence

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Medication | Treatment | Therapy | Surgery

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Mental Health | Wellbeing | Stress | Sleep

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Myths | Fake News | Science Mistrust

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Physical Health | Human Body | Sex

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Products | Supplements

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Racism | Inequality

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Science

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









Technology

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]









YouTube #Shorts

Demystifying pulmonary fibrosis with single cell RNA sequencing Podcast with Dr. Kaminski

Mar 17, 2021, 16:00 PM by Julie Vo and Rawan Al-Nasery
Dr. Naftali Kaminski, Professor at the Yale School of Medicine, has a laboratory where an IPF Cell Atlas has been built that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology.

Idiopathic pulmonary fibrosis (IPF) is one of many rare interstitial lung diseases that exist. It has an estimated prevalence of 13 to 20 per 100,000 people worldwide. Unfortunately, there is no cure.

Dr. Naftali Kaminski, Professor at the Yale School of Medicine, is one of the researchers that has been advancing our understanding of the molecular and cellular basis of the disease. Using single cell sequencing, his laboratory has built an IPF Cell Atlas that is helping define disease-specific transcriptional profiles and functions in disease pathophysiology. With his long standing research in pulmonary fibrosis, he has collaborated with global researchers to investigate the immunopathology of COVID-19.

With insights from a professional in the field, we will learn about the current research and efforts made by healthcare professionals to revolutionize immunophenotyping in advanced lung diseases.

[Please complete our feedback form]












Accessibility for Ontarians With Disabilities Act (AODA)

 

The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at fhsaoda@mcmaster.ca.